Fruquintinib Combined With Chemotherapy as Third-line /Third-line+ Treatment in Advanced Colorectal Cancer

Clinical trial NCT05928312 · UNKNOWN

Trial details

NCT number: NCT05928312
Sponsor: Zhejiang Cancer Hospital
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Advanced Colorectal Cancer

Start date: 2023-08-28
Primary completion: 2025-06-28
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.